TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive NCAB Hears Good News: FY 92 Budget Allows NCI To Increase Levels Of Most Programs November 29, 1991
TCL Archive Centers, Groups, Others May Land in DeVita’s Office; Hammer Offers Deal congress Can’t Refuse February 5, 1988
